XOSPATA 40MG TABLET 21'S

XOSPATA 40MG TABLET 21'S is generally not recommended for individuals with a history of seizures. Consult your doctor before using the medicine.

People may experience side effects, including dizziness, drowsiness, or fatigue, after using XOSPATA 40MG TABLET 21'S. In that case, avoid driving or operating heavy machinery.

Yes, you may experience diarrhea during the medication. Drink sufficient amounts of water and take electrolytes to compensate for the water loss caused by the drug. It is recommended to avoid spicy or junk foods, which can worsen the gastrointestinal problem.

Consult your healthcare provider if you plan to get pregnant. However, the medication has not been given to expectant mothers, and it should only be used when the projected advantages outweigh any possible hazards to the fetus. It is recommended to use an effective contraceptive for women who are of childbearing age.

XOSPATA 40MG TABLET 21'S works by blocking the enzyme (protein kinases), which is involved in the abnormal growth and multiplication of white blood cells. It also induces the apoptosis process in white blood cells that express the gene (FLT3-ITD) mutations.

Yes, XOSPATA 40MG TABLET 21'S can interact with other medicines. Always inform your doctor about all the medications, supplements, and herbal products you are currently taking to avoid potential interactions.

Drink plenty of water and take electrolytes, especially if you experience diarrhea. Avoid spicy or junk foods if they worsen stomach issues. Get enough rest to manage weakness or muscle/joint pain. Your doctor may monitor your blood pressure and heart function. Report any unusual symptoms promptly to your doctor.

The active ingredient in XOSPATA 40MG TABLET 21'S is GILTERITINIB.

XOSPATA 40MG TABLET 21'S is used to treat certain types of blood cancer, specifically relapsed or refractory acute myeloid leukemia (AML) in adults with a specific gene mutation (FLT3).

XOSPATA 40MG TABLET 21'S works by targeting and blocking certain enzymes (protein kinases) involved in cancer cell growth, especially in white blood cells with the FLT3-ITD mutation. This helps to reduce the growth and survival of these cancer cells.